Chemo-Free Treatment Extends Lung Cancer Survival

Published on January 7, 2025

Johnson & Johnson said on Tuesday its chemotherapy-free combination treatment showed a meaningful improvement in extending lives of patients with a type of lung cancer, compared to AstraZeneca’s blockbuster drug Tagrisso. The combination of J&J’s cancer drugs Rybrevant and…

Read Full Article (External Site)